Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2015

View Archived Issues

Sprint Bioscience and Bayer sign collaboration and license agreement for tumor metabolism program

Apogenix and R-Biopharm partner on companion diagnostics for APG-101

Foundation Medicine initiates study of circulating tumor DNA assay

Oragenics and Intrexon report positive activity for lantibiotics in C. difficile model

PhytoTech Medical completes acquisition of MMJ Bioscience

Viking Therapeutics to conduct phase II study of VK-2809

CDX-085 shows superior bioavailability to microalgal astaxanthin in monkey study

AEterna Zentaris reveals optimized ERK inhibitor and back-up compounds

Sumitomo Dainippon Pharma offers overview of first quarter of fiscal 2015

ARIAD to use ponatinib financing to develop brigatinib

Recombinant protein shows antitumor effect and improves paclitaxel efficacy

Tesaro and Jiangsu Hengrui medicine form rolapitant license agreement for China

Ascendis Pharma reports topline results from a phase II pediatric study of TransCon Growth Hormone

Roche patents neurogenesis-stimulating compounds

Bayer divulges MNK1 inhibitors

Aurigene introduces IRAK-4 inhibitors

Rgenix presents LXR agonists

Piramal patents EZH2 inhibitors

Novel myristoylated peptide aptamer acts as N-type calcium channel blocker for analgesic effects

Roche files PMA for EGFR mutation test as companion diagnostic to AZD-9291

Scripps Florida researchers receive two NIH grants

Scancell and ImmunID to use ImmunTraCkeR to predict response to SCIB-1

GI Dynamics ends pivotal U.S. trial of EndoBarrier

Mayo Clinic and Diadexus collaborate on PLAC Lp-PLA2 test

Eisai files for approval of eribulin in soft tissue sarcoma in U.S., E.U. and Japan

Kyowa Hakko Kirin files for Japanese approval of brodalumab

Takeda Pharmaceutical updates key activities of first quarter of fiscal 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...